![Matthias Schroff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthias Schroff
Vorstandsvorsitzender bei Inceptor Bio LLC
Profil
Matthias G.
Schroff is currently the Chief Executive Officer at Inceptor Bio LLC since 2023 and the Chief Operating Officer at Exicure Operating Co. since 2018.
Previously, he served as the Chief Executive Officer at Vaximm AG from 2016 to 2017, the President, Chief Executive Officer & Director at Exicure, Inc. from 2018 to 2023, and a Member-Executive Board at MOLOGEN AG from 2005 to 2015.
He also served as a Member-Supervisory Board at Verband Forschender Arzneimittelhersteller eV.
Dr. Schroff obtained his undergraduate degree from the University of Hannover and his doctorate degree from Freie Universität Berlin.
Aktive Positionen von Matthias Schroff
Unternehmen | Position | Beginn |
---|---|---|
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Geschäftsführer | 01.04.2018 |
Inceptor Bio LLC
![]() Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Vorstandsvorsitzender | 08.05.2023 |
Ehemalige bekannte Positionen von Matthias Schroff
Unternehmen | Position | Ende |
---|---|---|
EXICURE, INC. | Vorstandsvorsitzender | 26.04.2023 |
Vaximm AG
![]() Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Vorstandsvorsitzender | 31.12.2017 |
MOLOGEN AG | Vorstandsvorsitzender | 01.11.2015 |
Verband Forschender Arzneimittelhersteller eV
![]() Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Direktor/Vorstandsmitglied | - |
Ausbildung von Matthias Schroff
Freie Universität Berlin | Doctorate Degree |
University of Hannover | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MOLOGEN AG | Commercial Services |
EXICURE, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Verband Forschender Arzneimittelhersteller eV
![]() Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Commercial Services |
Vaximm AG
![]() Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
Inceptor Bio LLC
![]() Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Health Technology |